近日,2026 年美国放射肿瘤学会(American Society for Radiation Oncology,ASTRO)年会公布入选结果。复旦大学附属肿瘤医院放疗科共有31项临床与转化研究成功入选,包括14项口头报告、17项壁报讨论,研究覆盖消化道肿瘤、乳腺癌、肺癌、食管癌、放疗流行病学、放疗智能化技术等多个前沿方向,在国际舞台充分展示科室的综合实力与创新水平。
美国放射肿瘤学会(American Society for Radiation Oncology,ASTRO)成立于1958年,是全球放射肿瘤学领域最受关注的学术权威机构之一,总部位于美国弗吉尼亚州。
今年ASTRO年会主题为“以数据启共识:弘放疗之功,臻医业至善(Data to Dialogue: Communicating Radiotherapy's Value to Advance Care)”。学会汇聚全球超 10,000 名放疗医师、医学物理学家、放射生物学家及相关专业人员,主导制定大量国际放疗临床指南与质量标准,旗下《International Journal of Radiation Oncology・Biology・Physics》杂志为放疗领域顶级期刊。
Multimodal Artificial Intelligence Model for Predicting Treatment Efficacy and Optimizing Upfront Cranial Radiotherapy Selection in Third-Generation EGFR-TKI-Treated NSCLC with Brain Metastases
研究者:
庞叶纯, 朱雪茹, 彭林, 潘开成, 虞思来, 夏冰, 张莉, 余雯, 龚敬, 倪建佼, 朱正飞
03
在接受免疫治疗的晚期非小细胞肺癌中新发病灶进展风险对局部巩固治疗的生存获益的影响
Impact of Risk of New-Lesion Progression on Benefit of Local Consolidative Therapy in Immunotherapy-Treated Patients with Advanced Non-Small Cell Lung Cancer
Clinical Value and Optimal Timing of Cranial Stereotactic Radiotherapy for Limited Brain Metastases from First-Line Osimertinib-Treated Non-Small Cell Lung Cancer
Combining SBRT with GM-CSF and Peg-IFNα to Induce Abscopal Effects In Previously Treated Patients with Metastatic Thymic Tumors: A Single Institution, Phase II Trial
ADH1A rs7654607: A Key Variant for Paclitaxel-Aggravated Radiation Pneumonitis in Esophageal Cancer Chemoradiotherapy
研究者:
陈赟,汤天璐,张若昕,赵快乐
08
诱导化疗联合特瑞普利单抗在局部晚期喉癌下咽癌中的器官功能保留价值:INSIGHT研究3年随访
Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: 3-Year Follow-Up of the INSIGHT Study
Immunotherapy based total neoadjuvant therapy with or without short-course radiotherapy for locally advanced rectal cancer: initial results of TORCH-iTNT
Distinct Efficacy between Very Early-Onset Locally Advanced Rectal Cancer (VEO-LARC) and Late-Onset LARC Receiving Total Neoadjuvant Therapy with or without Immunotherapy
FAPI-Guided Radiotherapy + Cadonilimab with Systemic Therapy vs Systemic Therapy Alone in Second-Line Treatment of Colorectal Peritoneal Metastasis (TORCH-PM01)
研究者:
万觉锋,张致远,戴卫星,王人杰,章真,蔡国响
12
人工智能空间特征预测新辅助放化疗后直肠癌患者的早期复发:一项多模型消融研究
Spatiotemporal AI Morphometry Predicts Early Recurrence in Rectal Cancer Post-nCRT: A Multi-Model Ablation Study
Ten-Year Outcomes of the Phase III ESO-Shanghai 1 Trial: Comparing Paclitaxel Plus Fluorouracil Group versus Cisplatin Plus Fluorouracil Group in Definitive Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
Medium Dose of TPF Chemotherapy with Concurrent Radiotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Real-World Study
研究者:
范兴文,吴开良
06
中等剂量TPF方案放化疗联合免疫治疗局部晚期食管鳞癌:前瞻性Ⅱ期研究(FUTURE-2)
Medium Dose of TPF Chemotherapy with Concurrent Radiotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma:A Prospective, Single Arm, Phase II Study (FUTURE-2)
研究者:
范兴文,吴开良
07
局部晚期不可切除食管癌新辅助化疗联合免疫治疗后序贯同步放化疗的预后研究
Efficacy and Prognosis of Neoadjuvant Chemoimmunotherapy Followed by Concurrent Chemoradiotherapy in Unresectable Esophageal Cancer: The First Single-Center Real-World Study
Esophageal Squamous Cell Carcinoma–Derived Extracellular Vesicles Enhance Natural Killer Cell Antitumor Activity after Radiotherapy via the Mir-4516/TNFAIP3 Axis
研究者:
周月,杨曦,甘愉,朱正飞
09
一线第三代EGFR-TKI治疗下非小细胞肺癌脑转移灶的时空演变:颅内局部治疗最优时机的临床启示
Temporal Dynamics of Brain Metastatic Lesions from First-Line Third-Generation EGFR-TKI-Treated NSCLC: Implications for Optimal Timing of Cranial Local Therapy
Circulating Epstein-Barr Virus DNA Level Post Induction Chemotherapy Contributes to Prognostication in Nonmetastatic Nasopharyngeal Carcinoma Treated with Intensity Modulated Radiotherapy (IMRT) + Carbon-Ion Beam Radiotherapy (CIRT)
研究者:
李玉姣,胡超苏
11
放疗联合化学免疫治疗序贯手术用于伴有局限性淋巴结转移的胃癌:MIRACLE-G研究的初步结果
Radiotherapy plus Chemoimmunotherapy Followed by Surgery for Gastric Cancer with Limited Lymph Node Metastases: Preliminary Results from the MIRACLE-G Study
Neoadjuvant short-course radiotherapy combined with immunochemotherapy vs chemotherapy alone in pMMR colon cancers: The TORCH-C Randomized phase II Clinical Trial
Should tumor-draining lymph nodes be spared from irradiation during immunotherapy? Insights from T cell analysis in patients with locally advanced rectal cancer
研究者:
陈思远,周淑娟,夏凡,章真
14
免疫增敏的趋同机制:单细胞测序揭示接受抗PD-1±短程放疗治疗直肠癌中共同的肿瘤微环境重塑途径
Convergent Mechanisms of Immune Sensitization: scRNA-seq Reveals Shared TME Remodeling Pathway in Rectal Cancer Treated with Anti-PD-1 ± SCRT
Longitudinal Single-Cell RNA Sequencing Highlights Distinct Tumor Microenvironment Dynamics between Very Early-Onset and Late-Onset Locally Advanced Rectal Cancer Receiving Immunotherapy-Based Total Neoadjuvant Therapy
Hypofractionated radiotherapy combined with immunotherapy and chemotherapy for locally recurrent rectal cancer (TORCH-R): a prospective, single-arm, two-cohort, phase II trial
研究者:
伍瑞燕,刘宇峻,夏凡,申丽君,黄莉莉,王雁,张慧,王雅琪,周淑娟,万觉锋, 章真
17
基于深度学习的胸部放疗自动计划预评估:在计划前预测计划可实现性
Deep Learning–Based Pre-Assessment for Thoracic Radiotherapy Auto-Planning: Predicting Plan Achievability before Planning